RxDoctor Payments DataLook up a doctor →

Amanda Appling, PA

Physician Assistant · Cumming, GANPI 1386938611

Payments from drug & device makers

$19,097in general payments, 2019–2025

Across 924 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • UCB, Inc.$3K
  • Amgen$3K
  • Johnson & Johnson$2K
  • Novartis$1K
  • Mallinckrodt Hospital Products Inc.$1K
  • plus $6K from 28 others

What the payments were for

  • Consulting fees$1,0806%
  • Travel & lodging$320%
  • Food & beverage$17,68693%
  • Education$2992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,097 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$6,206
Medicare patients
54
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa11$238,127
Enbrel SureclickEtanercept24$175,740
Humira(Cf) PenAdalimumab24$159,990
ProliaDenosumab16$27,377
RasuvoMethotrexate/Pf17$11,623
Hydroxychloroquine Sulfate242$9,574
Duloxetine Hcl186$3,483
MethotrexateMethotrexate Sodium164$2,072
Diclofenac Sodium38$1,751
Leflunomide51$1,172
Prednisone198$1,049
Pregabalin70$985
Allopurinol60$794
Gabapentin77$784
Ibandronate Sodium15$744

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenProlia$2,720$27,37716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Cumming

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →